世界の癌ワクチン市場2020-2027:種類別(予防的癌ワクチン、治療的癌ワクチン)、技術別、疾患別、エンドユーザー別、地域別

◆英語タイトル:Global Cancer Vaccines Market Size study, by Type (Preventive Cancer Vaccines, Therapeutic Cancer Vaccines), by Technology (Dendritic Cells (DC) Cancer Vaccines, Recombinant Cancer Vaccines, Antigen/Adjuvant Cancer Vaccines, Viral Vector & DNA Cancer Vaccines), by Indication (Cervical Cancer, Prostate Cancer, Others), by End-User (Pediatrics, Adults) and Regional Forecasts 2020-2027
◆商品コード:BZW20ST026
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2020年8月28日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、日本、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD4,950 ⇒換算¥544,500見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD6,250 ⇒換算¥687,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、癌ワクチンの世界市場を調査・分析することにより、エグゼクティブサマリー、市場定義・範囲、市場動向、産業分析、種類別(予防的癌ワクチン、治療的癌ワクチン)分析、技術別分析、疾患別分析、エンドユーザー別分析、地域別分析、競争状況、調査プロセスなどの内容を含め、今後の市場性を展望することを目的とする。
・エグゼクティブサマリー
・市場定義・範囲
・市場動向
・産業分析
・癌ワクチンの世界市場規模:種類別(予防的癌ワクチン、治療的癌ワクチン)
・癌ワクチンの世界市場規模:技術別
・癌ワクチンの世界市場規模:疾患別
・癌ワクチンの世界市場規模:エンドユーザー別
・癌ワクチンの世界市場規模:地域別
・競争状況
・調査プロセス
【レポートの概要】

Global Cancer Vaccines Market is valued at approximately USD 4.2 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 12.6% over the forecast period 2020-2027. Cancer vaccines are a form of immunotherapy which is considered as a biological response modifier. Usually, cancer treatment vaccines are distinct from the vaccines that work against bacteria and viruses. Cancer vaccines can stimulate the immune system of the patient’s body to fight against cancer cells. Rather than preventing disease, these vaccines are primarily focused to boost the immune systems to medicate a disease that already occurred in the patient’s body.

The cancer vaccines are generally available in two types i.e. preventive cancer vaccines and therapeutic cancer vaccines. Preventive cancer vaccines are typically used to prevent cancer disease among healthy people, whereas therapeutic cancer vaccines are used to strengthen the immune response among patients to fight against the disease. An increase in the number of cancer patients, growing awareness among patients towards cancer therapy, and rising investment and government funding in the development of cancer vaccine are the few factors responsible for the CAGR of the market during the forecast period.

According to the International Agency for Research on Cancer (IARC), around 18.1 million new cancer cases and 9.6 million cancer deaths were reported throughout the world in 2018. Also, the global prevalence of cancer is projected to grow to around 27.5 million new cancer cases and nearly 16.3 million cancer deaths by the year 2040. This, in turn, is likely to strengthen the demand for Cancer Vaccines, globally. However, the high development cost of vaccine and stringent government norms & policies on product approval are the few factors impeding the market growth over the forecast period of 2020-2027.

The regional analysis of the global Cancer Vaccines market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the favorable government support for the approval of cancer vaccines, along with the wide presence of market players in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of cancer and improving healthcare infrastructure in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the cancer vaccine market in the Asia-Pacific region.

Major market player included in this report are:
Advaxis Inc.
Amgen Inc.
Dynavax Technologies Corporation
Generex Biotechnology Corporation
GlaxoSmithKline plc (GSK)
Immunocellular Therapeutics, Ltd.
Merck & Co., Inc.
Sanpower Group Co. Ltd.
UbiVac, Inc.
Vaccinogen, Inc.

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Preventive Cancer Vaccines
Therapeutic Cancer Vaccines

By Technology:
Dendritic Cells (DC) Cancer Vaccines
Recombinant Cancer Vaccines
Antigen/Adjuvant Cancer Vaccines
Viral Vector & DNA Cancer Vaccines

By Indication:
Cervical Cancer
Prostate Cancer
Others

By End-User:
Pediatrics
Adults

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:
Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Cancer Vaccines Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Cancer Vaccines Market, by Region, 2018-2027 (USD Billion)
1.2.2. Cancer Vaccines Market, by Type, 2018-2027 (USD Billion)
1.2.3. Cancer Vaccines Market, by Technology, 2018-2027 (USD Billion)
1.2.4. Cancer Vaccines Market, by Indication, 2018-2027 (USD Billion)
1.2.5. Cancer Vaccines Market, by End-User, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Cancer Vaccines Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Cancer Vaccines Market Dynamics
3.1. Cancer Vaccines Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Cancer Vaccines Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Cancer Vaccines Market, by Type
5.1. Market Snapshot
5.2. Global Cancer Vaccines Market by Type, Performance – Potential Analysis
5.3. Global Cancer Vaccines Market Estimates & Forecasts by Type 2017-2027 (USD Billion)
5.4. Cancer Vaccines Market, Sub Segment Analysis
5.4.1. Preventive Cancer Vaccines
5.4.2. Therapeutic Cancer Vaccines
Chapter 6. Global Cancer Vaccines Market, by Technology
6.1. Market Snapshot
6.2. Global Cancer Vaccines Market by Technology, Performance – Potential Analysis
6.3. Global Cancer Vaccines Market Estimates & Forecasts by Technology 2017-2027 (USD Billion)
6.4. Cancer Vaccines Market, Sub Segment Analysis
6.4.1. Dendritic Cells (DC) Cancer Vaccines
6.4.2. Recombinant Cancer Vaccines
6.4.3. Antigen/Adjuvant Cancer Vaccines
6.4.4. Viral Vector & DNA Cancer Vaccines
Chapter 7. Global Cancer Vaccines Market, by Indication
7.1. Market Snapshot
7.2. Global Cancer Vaccines Market by Indication, Performance – Potential Analysis
7.3. Global Cancer Vaccines Market Estimates & Forecasts by Indication 2017-2027 (USD Billion)
7.4. Cancer Vaccines Market, Sub Segment Analysis
7.4.1. Cervical Cancer
7.4.2. Prostate Cancer
7.4.3. Others
Chapter 8. Global Cancer Vaccines Market, by End-User
8.1. Market Snapshot
8.2. Global Cancer Vaccines Market by End-User – Potential Analysis
8.3. Global Cancer Vaccines Market Estimates & Forecasts by End-User 2017-2027 (USD Billion)
8.4. Cancer Vaccines Market, Sub Segment Analysis
8.4.1. Paediatrics
8.4.2. Adults
Chapter 9. Global Cancer Vaccines Market, Regional Analysis
9.1. Cancer Vaccines Market, Regional Market Snapshot
9.2. North America Cancer Vaccines Market
9.2.1. U.S. Cancer Vaccines Market
9.2.1.1. Type breakdown estimates & forecasts, 2017-2027
9.2.1.2. Technology breakdown estimates & forecasts, 2017-2027
9.2.1.3. Indication breakdown estimates & forecasts, 2017-2027
9.2.1.4. End-User breakdown estimates & forecasts, 2017-2027
9.2.2. Canada Cancer Vaccines Market
9.3. Europe Cancer Vaccines Market Snapshot
9.3.1. U.K. Cancer Vaccines Market
9.3.2. Germany Cancer Vaccines Market
9.3.3. France Cancer Vaccines Market
9.3.4. Spain Cancer Vaccines Market
9.3.5. Italy Cancer Vaccines Market
9.3.6. Rest of Europe Cancer Vaccines Market
9.4. Asia-Pacific Cancer Vaccines Market Snapshot
9.4.1. China Cancer Vaccines Market
9.4.2. India Cancer Vaccines Market
9.4.3. Japan Cancer Vaccines Market
9.4.4. Australia Cancer Vaccines Market
9.4.5. South Korea Cancer Vaccines Market
9.4.6. Rest of Asia Pacific Cancer Vaccines Market
9.5. Latin America Cancer Vaccines Market Snapshot
9.5.1. Brazil Cancer Vaccines Market
9.5.2. Mexico Cancer Vaccines Market
9.6. Rest of The World Cancer Vaccines Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Advaxis Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Amgen Inc.
10.2.3. Dynavax Technologies Corporation
10.2.4. Generex Biotechnology Corporation
10.2.5. GlaxoSmithKline plc (GSK)
10.2.6. Immunocellular Therapeutics, Ltd.
10.2.7. Merck & Co., Inc.
10.2.8. Sanpower Group Co. Ltd.
10.2.9. UbiVac, Inc.
10.2.10. Vaccinogen, Inc.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

TABLE 1. Global Cancer Vaccines market, report scope
TABLE 2. Global Cancer Vaccines market estimates & forecasts by region 2017-2027 (USD Billion)
TABLE 3. Global Cancer Vaccines market estimates & forecasts by Type 2017-2027 (USD Billion)
TABLE 4. Global Cancer Vaccines market estimates & forecasts by Technology 2017-2027 (USD Billion)
TABLE 5. Global Cancer Vaccines market estimates & forecasts by Indication 2017-2027 (USD Billion)
TABLE 6. Global Cancer Vaccines market estimates & forecasts by End-User 2017-2027 (USD Billion)
TABLE 7. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 8. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 9. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 10. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 11. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 12. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 13. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 14. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 15. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 16. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 17. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 18. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 19. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 20. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 21. Global Cancer Vaccines market by segment, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 22. Global Cancer Vaccines market by region, estimates & forecasts, 2017-2027 (USD Billion)
TABLE 23. U.S. Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 24. U.S. Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 25. U.S. Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 26. Canada Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 27. Canada Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 28. Canada Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 29. UK Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 30. UK Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 31. UK Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 32. Germany Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 33. Germany Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 34. Germany Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 35. France Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 36. France Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 37. France Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 38. Spain Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 39. Spain Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 40. Spain Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 41. Italy Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 42. Italy Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 43. Italy Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 44. ROE Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 45. ROE Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 46. ROE Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 47. China Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 48. China Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 49. China Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 50. India Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 51. India Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 52. India Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 53. Japan Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 54. Japan Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 55. Japan Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 56. Australia Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 57. Australia Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 58. Australia Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 59. South Korea Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 60. South Korea Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 61. South Korea Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 62. ROPAC Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 63. ROPAC Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 64. ROPAC Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 65. Brazil Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 66. Brazil Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 67. Brazil Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 68. Mexico Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 69. Mexico Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 70. Mexico Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 71. ROLA Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 72. ROLA Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 73. ROLA Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 74. ROW Cancer Vaccines market estimates & forecasts, 2017-2027 (USD Billion)
TABLE 75. ROW Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 76. ROW Cancer Vaccines market estimates & forecasts by segment 2017-2027 (USD Billion)
TABLE 77. List of secondary End-Users, used in the study of global Cancer Vaccines market
TABLE 78. List of primary End-Users, used in the study of global Cancer Vaccines market
TABLE 79. Years considered for the study
TABLE 80. Exchange rates considered

FIG 1. Global Cancer Vaccines market, research methodology
FIG 2. Global Cancer Vaccines market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Cancer Vaccines market, key trends 2019
FIG 5. Global Cancer Vaccines market, growth prospects 2020-2027
FIG 6. Global Cancer Vaccines market, porters 5 force model
FIG 7. Global Cancer Vaccines market, pest analysis
FIG 8. Global Cancer Vaccines market, value chain analysis
FIG 9. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
FIG 10. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
FIG 11. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
FIG 12. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
FIG 13. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
FIG 14. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
FIG 15. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
FIG 16. Global Cancer Vaccines market by segment, 2017 & 2027 (USD Billion)
FIG 17. Global Cancer Vaccines market, regional snapshot 2017 & 2027
FIG 18. North America Cancer Vaccines market 2017 & 2027 (USD Billion)
FIG 19. Europe Cancer Vaccines market 2017 & 2027 (USD Billion)
FIG 20. Asia-Pacific Cancer Vaccines market 2017 & 2027 (USD Billion)
FIG 21. Latin America Cancer Vaccines market 2017 & 2027 (USD Billion)
FIG 22. Global Cancer Vaccines market, company market share analysis (2019)

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の癌ワクチン市場2020-2027:種類別(予防的癌ワクチン、治療的癌ワクチン)、技術別、疾患別、エンドユーザー別、地域別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆